The MIRI was very well represented at the annual Perinatal Research Society Annual Meeting Utah from September 29-October 1, in the beautiful setting of Park City.
A new, three-year NIH grant will expand Dr. Elizabeth Yen's research and initial pilot study findings about the effects of prenatal opioid exposure in an infant's first year of life.
Tufts Medicine announced today that Perrie O'Tierney-Ginn, PhD, has been named the permanent Executive Director of the Mother Infant Research Institute (MIRI) at Tufts Medical Center. She had served as the Interim Executive Director of MIRI since September 2021.
Taysir Mahmoud holds the newly created position of Supervisor of Clinical and Translational Research in MIRI, OB/Gyn and Pediatrics to accomplish that task.
In order to further strengthen the connection between the MIRI and investigators involved in complementary work across Tufts Medicine and Tufts University, MIRI created the role of "Associate PI."
MIRI PI Patrick Catalano, MD, has been awarded an R21 from the NIH/NICHD as Multi-Site PI for a two-year study entitled, “Impact of a Postpartum Lifestyle Intervention on Lactation Outcomes, Breastmilk Composition and Infant Growth.”
Michael House, MD, has been recognized as an expert in the uterine cervix, has received an SMFM/ABOG Bridge Grant entitled “Novel tools for studying cervical function and dysfunction during pregnancy.”
Dr. Elizabeth Yen, a neonatologist at Tufts Medical Center, has joined as PI. Dr. Yen’s lab conducts non-invasive salivary transcriptomic and brain magnetic imaging studies to understand the impact of the prenatal opioid exposure on the developing brain.